Detection of mutations and polymorphism of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations

被引:17
作者
Zhao, B
Lee, EJD
Yeoh, PN
Gong, NH
机构
[1] Natl Univ Singapore, Dept Pharmacol, Singapore 119260, Singapore
[2] Univ Malaya, Dept Pharmacol, Kuala Lumpur 59100, Malaysia
来源
PHARMACOGENETICS | 1998年 / 8卷 / 04期
关键词
N-acetyltransferase-1; polymorphism; Indians; Malays; Chinese;
D O I
10.1097/00008571-199808000-00003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The xenobiotic metabolizing enzymes N-acetyltransferases (NATs) are important for the biotransformation and/or bioactivation of drugs and carcinogens. NATs are coded for in humans by two distinct genes, designated NAT1 and NAT2, NAT1, which was originally thought to be monomorphic, was recently reported to exhibit variation in human populations, Recent studies suggested that a genetic polymorphism of NAT1 may be associated with colorectal cancer risk. The distributions of NAT1 allele and genotype frequencies in unrelated individuals among Indian (n = 140), Malay (n = 122) and Chinese (n = 181) populations in Singapore were characterized by polymerase chain reaction-restriction fragment length polymorphism and allele-specific-polymerase chain reaction, The allelic frequencies of NAT1*3, NAT1*4, NAT1*10 and NAT1*11 among Indians were 0,3, 0.51, 0.17 and 0.02, respectively. The corresponding NAT1 allelic frequencies in Malays were 0.29, 0.30, 0.39 and 0.02, respectively, and were similar to those in Chinese in the region. The allelic frequencies of NAT1*3, NAT1*4, NAT1*10 and NAT1*11 among Chinese were 0.33, 0.35, 0.30 and 0.02, respectively, These findings are of importance for the determination of cancer risk. in these populations. In addition, nucleotide changes at positions 350-351 (GG to CC) and 497-99 (GGG to CCC) of the NAT1 gene were not found in the alleles of the populations studied. Pharmacogenetics 8:299-304 (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 19 条
[1]  
BELL DA, 1995, CANCER RES, V55, P3537
[2]  
BELL DA, 1995, CANCER RES, V55, P5226
[3]   HUMAN ARYLAMINE N-ACETYLTRANSFERASE GENES - ISOLATION, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL EXPRESSION [J].
BLUM, M ;
GRANT, DM ;
MCBRIDE, W ;
HEIM, M ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1990, 9 (03) :193-203
[4]   STRUCTURE AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM OF GENES FOR HUMAN LIVER ARYLAMINE N-ACETYLTRANSFERASES [J].
EBISAWA, T ;
DEGUCHI, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (03) :1252-1257
[5]   GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].
EVANS, DAP ;
MANLEY, KA ;
MCKUSICK, VA .
BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491
[6]  
FREDERICKSON SM, 1994, CANCER EPIDEM BIOMAR, V3, P25
[7]  
GRANT DM, 1991, MOL PHARMACOL, V39, P184
[8]   METABOLIC-ACTIVATION AND DEACTIVATION OF ARYLAMINE CARCINOGENS BY RECOMBINANT HUMAN NAT1 AND POLYMORPHIC NAT2 ACETYLTRANSFERASES [J].
HEIN, DW ;
DOLL, MA ;
RUSTAN, TD ;
GRAY, K ;
FENG, Y ;
FERGUSON, RJ ;
GRANT, DM .
CARCINOGENESIS, 1993, 14 (08) :1633-1638
[9]  
KIRLIN WG, 1989, CANCER RES, V49, P2448
[10]   N-ACETYLATION AND O-ACETYLATION OF AROMATIC AND HETEROCYCLIC AMINE CARCINOGENS BY HUMAN MONOMORPHIC AND POLYMORPHIC ACETYLTRANSFERASES EXPRESSED IN COS-1 CELLS [J].
MINCHIN, RF ;
REEVES, PT ;
TEITEL, CH ;
MCMANUS, ME ;
MOJARRABI, B ;
ILETT, KF ;
KADLUBAR, FF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (03) :839-844